Toxicological analysis and antihyperalgesic, antidepressant, and anti-inflammatory effects of Campomanesia adamantium fruit barks

Nutritional Neuroscience

Volumn 20, Issue 1, 2017, Pages 23-31

  de Souza, Juliane C ^a   Piccinelli, Ana Cláudia ^a   Aquino, Diana F S ^a   de Souza, Vanessa V ^a   Schmitz, Wanderlei O ^a   Traesel, Giseli K ^a   Cardoso, Claudia A L ^b   Kassuya, Candida A L ^a   Arena, Arielle C ^a,c  

^a UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

^b UNIVERSIDADE ESTADUAL DE MATO GROSSO DO SUL   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Campomanesia adamantium fruit bark; Depression; Hyperalgesia; Inflammation; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CAMPOMANESIA ADAMANTIUM EXTRACT; DEXAMETHASONE; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CAMPOMANESIA ADAMANTIUM; CARRAGEENAN-INDUCED PLEURISY; COLD SENSITIVITY; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIM TEST; FRUIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPERALGESIA; IMMOBILITY; LEUKOCYTE COUNT; MALE; MEDICINAL PLANT; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING; ADVERSE EFFECTS; ANIMAL; BRAZIL; CHEMISTRY; COLD; DIETARY SUPPLEMENT; DOSE RESPONSE; ETHNOPHARMACOLOGY; MYRTACEAE; NEURALGIA; PLEURISY; TRADITIONAL MEDICINE; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; BRAZIL; COLD TEMPERATURE; DEPRESSION; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHNOPHARMACOLOGY; FEMALE; FRUIT; HYPERALGESIA; MALE; MEDICINE, TRADITIONAL; MYRTACEAE; NEURALGIA; PLANT BARK; PLANT EXTRACTS; PLEURISY; RATS, WISTAR; TOXICITY TESTS, ACUTE; TOXICITY TESTS, SUBACUTE;

EID: 84978483950     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830514Y.0000000145     Document Type: Article

References (29)

1. Alvarado S, Tajerian M, Millecamps M, Suderman M, Stone LS, Szyf M. Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex. Mol Pain 2013;9:1–12.
2. Melo JG, Santos AG, Amorim ELC, Nascimento SC, Albuquerque UP. Medicinal plants used as antitumor agents in Brazil:an ethnobotanical approach. Evid Based Complement Altern Med 2011;2011:1–14.
3. Ramos DD, Cardoso CAL, Yamamoto NT. Avaliação do potencial citotóxico e atividade antioxidante em Campomanesia adamantium (Cambess.) O. Berg (Myrtaceae). Rev Bras Biociênc 2007;5:774–6.
4. Vallilo MI, Lamardo LCA, Gaberlotti ML, Oliveira E, Moreno PRH. Composição química dos frutos de Campomanesia adamantium (Cambessédes) O. Berg. Ciênc Tecnol Aliment 2006;26:805–10.
5. Coutinho ID, Cardoso CAL, Ré-Poppi N, Melo AM, Vieira MC, Honda NK, et al. Gas chromatography-mass spectrometry (GC-MS) and evaluation of antioxidant and antimicrobial activities of essential oil of Campomanesia adamantium (Cambess.) O. Berg (Guavira). Braz J Pharm Sci 2009;45:767–75.
6. Pavan FR, Leite CQF, Coelho RG, Coutinho ID, Honda NK, Cardoso CAL, et al. Evaluation of anti-Mycobacterium tuberculosis activity of Campomanesia adamantium (Myrtaceae). Quím Nova 2009;32:1222–6.
7. Coutinho ID, Kataoka VMF, Honda NK, Coelho RG, Vieira MC, Cardoso CAL. Influência da variação sazonal nos teores de flavonoides e atividade antioxidante das folhas de Campomanesia adamantium (Cambess.) O. Berg, Myrtaceae. Rev Bras Farmacogn 2010;20:322–7.
8. Coutinho ID, Kataoka VMF, Honda NK, Silva JRM, Vilegas W, Cardoso CAL. Determination of phenolic compounds and evaluation of antioxidant capacity of Campomanesia adamantium leaves. Ecl Quím 2008;33:53–60.
9. Ferreira LC, Guimarães AG, Paula CA, Michel MCP, Guimarães RG, Rezende SA, et al. Anti-inflammatory and antinociceptive activities of Campomanesia adamantium. J Ethnopharmacol 2013;145:100–8.
10. Organisation for Economic Co-operation and Development (OECD). Guideline 407:repeated dose 28-day oral toxicity study in rodents; updated with parameters for endocrine effects. Paris; 2006.
11. Organisation for Economic Co-operation and Development (OECD). Guideline 425:acute oral toxicity–up-and-down-procedure. Paris:Head of Publications Service 2008;4:27.
12. Brazilian Health Surveillance Agency. Guide for conducting non-clinical safety studies required for drug development. ANVISA 2010;1:37.
13. Ha H, Lee JK, Lee HY, Koh WS, Seo CS, Lee MY, et al. Safety evaluation of Yukmijihwang-tang:assessment of acute and subchronic toxicity in rats. Evid Based Complement Altern Med 2011;2011:1–8.
14. Velo GP, Dunn CJ, Giroud JP, Timsit J, Willoughby DA. Distribution of prostaglandins in inflammatory exudate. J Pathol 1973;111:149–58.
15. Oliveira AM, Conserva LM, Ferro JNS, Brito FA, Lemos RPL, Barreto E. Antinociceptive and anti-inflammatory effects of octacosanol from the leaves of Sabicea grisea var. grisea in mice. Int J Mol Sci 2012;13:1598–611.
16. Bourquin AF, Süveges M, Pertin M, Gilliard N, Sardy S, Davison AC, et al. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 2006;122:1–14.
17. Ito S, Okuda-Ashitaka E, Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 2001;41:299–332.
18. Decosterd I, Woolf CJ. Spared nerve injury:an animal model of persistent peripheral neuropathic pain. Pain 2000;87:149–58.
19. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats:a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379–91.
20. Lapchik VBV, Mattaraia VGM, Ko GM. Cuidados e Manejo de Animais de Laboratório. São Paulo:Atheneu Editora; 2009.
21. Giraldo LB, Hernández MMP, Angulo PH, Fuertes CR. Actividad antinitrosativa y antiinflamatoria de los flavonoides de las hojas de Uncaria tomensosa Willd. D. C. (uña de gato). RevSoc Quím Perú 2003;69:229–42.
22. Zhang G-F, Wang N, Shi J-Y, Xu S-X, Li X-M, Ji M-H, et al. Inhibition of the L-arginine-nitric oxide pathway mediates the antidepressant effects of ketamine in rats in the forced swimming test. Pharmacol Biochem Behav 2013;110:8–12.
23. Wang J, Goffer Y, Xu D, Tukey DS, Shamir D, Eberle SE, et al. A single sub-anesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 2011;115(4):812.
24. Zhou Z, Zhang G, Li X, Liu X, Wang N, Qiu L, et al. Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration. Mol Neurobiol 2014;51(2):808–819.
25. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens Jr WC, et al. Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 2003;305:323–30.
26. Gould TD, Einat H, Bhat R, Manji HK. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 2004;7:387–90.
27. Yang C, Hong T, Shen J, Ding J, Dai XW, Zhou ZQ, et al. Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus. Exp Ther Med 2013;5:1093–6.
28. Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology 2012;20:331–41.
29. Pathak L, Agrawal Y, Dhir A. Natural polyphenols in the management of major depression. Expert Opin Invest Drugs 2013;22:863–80.